Correlation Between Purple Biotech and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Ascendis Pharma AS, you can compare the effects of market volatilities on Purple Biotech and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Ascendis Pharma.
Diversification Opportunities for Purple Biotech and Ascendis Pharma
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Purple and Ascendis is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Purple Biotech i.e., Purple Biotech and Ascendis Pharma go up and down completely randomly.
Pair Corralation between Purple Biotech and Ascendis Pharma
Given the investment horizon of 90 days Purple Biotech is expected to generate 15.48 times more return on investment than Ascendis Pharma. However, Purple Biotech is 15.48 times more volatile than Ascendis Pharma AS. It trades about 0.24 of its potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.14 per unit of risk. If you would invest 297.00 in Purple Biotech on September 4, 2024 and sell it today you would earn a total of 543.00 from holding Purple Biotech or generate 182.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Purple Biotech vs. Ascendis Pharma AS
Performance |
| Timeline |
| Purple Biotech |
| Ascendis Pharma AS |
Purple Biotech and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Ascendis Pharma
The main advantage of trading using opposite Purple Biotech and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
| Ascendis Pharma vs. Apellis Pharmaceuticals | Ascendis Pharma vs. BeiGene | Ascendis Pharma vs. Akero Therapeutics | Ascendis Pharma vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |